DOSE DENSE ABVD (DD-ABVD) AS FIRST LINE THERAPY IN EARLY-STAGE UNFAVOURABLE HODGKIN LYMPHOMA (CHL): RESULTS OF A PHASE II, PROSPECTIVE, MULTI-CENTER STUDY BY FONDAZIONE ITALIANA LINFOMI
Mazza, R., Spina, M., Califano, C., Gaudio, F., Carella, M., Consoli, U., Palombi, F., Musso, M., Pulsoni, A., Kovalchuk, S., Bonfichi, M., Ricci, F., Fabbri, A., Liberati, A. M., Rodari, M., GiordanoVolume:
3
Language:
english
Journal:
HemaSphere
DOI:
10.1097/01.HS9.0000563228.79887.e0
Date:
June, 2019
File:
PDF, 571 KB
english, 2019